logo
Select company
Select metric
$ -14.63KInterest Expense
VS
Market
96
Sector
96
Industry
96
History
89
$ 3.31Close
$ 3.31 - $ 570.6 52-Week Range
Ticker Information

Ticker

CERO

Company Name

CERO THERAPEUTICS HOLDINGS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CERO THERAPEUTICS HOLDINGS INC - Interest Expense Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CERO - Int. Exp. Historical data
DateInterest Expense
6/30/2025$ -14.63K
3/31/2025$ -17.83K
12/31/2024$ 0
12/31/2023$ 0
9/30/2023$ 0
6/30/2023$ 0
3/31/2023$ 0
12/31/2022$ 0
6/30/2022$ 0
12/31/2021$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CERO THERAPEUTICS HOLDINGS INC's latest trailing twelve months (TTM) Int. Exp. stands at $ 0.
  • Over the past 5 years, CERO THERAPEUTICS HOLDINGS INC's average Int. Exp. has been $ -3.25K.
  • The median Int. Exp. for CERO THERAPEUTICS HOLDINGS INC during this period was $ 0
  • CERO THERAPEUTICS HOLDINGS INC reached its highest Int. Exp. over the past 5 years at $ 0.
  • The lowest Int. Exp. recorded by CERO THERAPEUTICS HOLDINGS INC in the same timeframe $ -17.83K

Similar metrics to Int. Exp.:

Definition of Interest Expense

[Income Statement] Interest expense is the cost incurred by a business for borrowing funds.

CERO - Interest Expense, Last 5 years

$ -17.83K

Minimum

Mar 31, 2025

$ 0

Maximum

Dec 31, 2021

$ -3.25K

Average

$ 0

Median

Int. Exp. Benchmark Analysis

 The chart above depicts the distribution of Int. Exp. for companies in the Total Stock Market. The average Int. Exp. of the companies is $ 2.81M with a standard deviation of $ 5.59M.
The following table provides additional summary stats:
Int. Exp. in the Market:
filtered constituents2.73K
min$ -15.41M
max$ 23.09M
average$ 2.81M
median$ 19.42K
std$ 5.59M